2016

Practical management of myelofibrosis with ruxolitinib.

Ho PJ, Marlton P, Tam C, Stevenson W, Ritchie D, Bird R, Dunlop LC, Durrant S, Ross DM (2015).

Intern Med J 2016; 45:1221-30.

2016

International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment.

Dimopoulos MA, Sonneveld P, Leung N, Merlini G, Ludwig H, Kastritis E, Goldschmidt H, Joshua D, Orlowski RZ, Powles R, Vesole DH, Garderet L, Einsele H, Palumbo A, Cavo M, Richardson PG, Moreau P, San Miguel J, Rajkumar SV, Durie BG, Terpos E.

J Clin Oncol. 2016 May 1;34(13):1544-57. doi: 10.1200/JCO.2015.65.0044.

2016

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation.

Nath CE, Trotman J, Tiley C, Presgrave P, Joshua D, Kerridge I, Kwan YL, Gurney H, McLachlan AJ, Earl JW, Nivison-Smith I, Zeng L, Shaw PJ.

Br J Clin Pharmacol. 2016 Jul;82(1):149-59. doi: 10.1111/bcp.12906.

2016

Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation.

Prahlad V. Raninga, Giovanna Di Trapani, Slavica Vuckovic, Kathryn F. Tonissen.

Apoptosis ‎2016;21:1422-1437.

2016

Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.

Guillerey C, Nakamura K, Vuckovic S, Hill GR, Smyth MJ.

Cell Mol Life Sci. 2016. Review

2016

Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.

Raninga PV, Di Trapani G, Vuckovic S, Tonissen KF.

Redox Biol. 2016;8: 175-185.

2016

TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-small ka, Cyrillicbeta inhibition.

Raninga PV, Di Trapani G, Vuckovic S, Tonissen KF.

Cell Cycle. 2016: 15:559-72.

2016

Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute graft-versus-host disease.

Tey, S.K.; Vuckovic, S.; Varelias, A.; Martins, J.P.; Olver, S.; Samson, L.; Sturgeon, E.; Leach, J.; Avery, J.; Nakagaki, M,; Butler, J.P.; Curley, C.; Morton, A.J.; Durrant, S.T.; Kennedy, G.A.; Hill, G.R.

Bone Marrow Transplant, 2016;51:1153-1155.

2016

The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population.

Ju X, Silveira PA, Hsu WH, Elgundi Z, Alingcastre R, Verma ND, Fromm PD, Hsu JL, Bryant C, Li Z, Kupresanin F, Lo TH, Clarke C, Lee K, McGuire H, Fazekas de St Groth B, Larsen SR, Gibson J, Bradstock KF, Clark GJ, Hart DN.

J Immunol. 2016 Dec 15;197(12):4613-4625.

2016

The T Cell in Myeloma. Clin Lymphoma Myeloma Leuk.

Joshua D, Suen H, Brown R, Bryant C, Ho PJ, Hart D, Gibson J.

2016 Oct;16(10):537-542. doi: 10.1016/j.clml.2016.08.003. Epub 2016 Aug 10. Review.

2016

CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.

Fromm PD, Papadimitrious MS, Hsu JL, Van Kooten Losio N, Verma ND, Lo TH, Silveira PA, Bryant CE, Turtle CJ, Prue RL, Vukovic P, Munster DJ, Nagasaki T, Barnard RT, Mahler SM, Anguille SA, Berneman Z, Horvath LG, Bradstock KF, Joshua DE, Clark GJ, Hart DN.

Oncoimmunology. 2016 May 5;5(6):e1168555. doi: 10.1080/2162402X.2016.1168555.

2016

New insights into the phenotype of human dendritic cell populations.

Clark GJ, Kupresanin F, Fromm PD, Ju X, Muusers L, Silveira PA, Elgundi Z, Gasiorowski RE, Papadimitrious MS, Bryant C, Lee KM, Clarke CJ, Young JW, Chan A, Harman A, Botting R, Cabezón R, Benitez-Ribas D, Brooks AE, Dunbar PR, Hart DN.

Clin Transl Immunology. 2016 Jan 29;5(1):e61. doi: 10.1038/cti.2015.40.

2016

A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset.

Bryant C, Fromm PD, Kupresanin F, Clark G, Lee K, Clarke C, Silveira PA, Suen H, Brown R, Newman E, Cunningham I, Ho PJ, Gibson J, Bradstock K, Joshua D, Hart DNj.

Immunol Cell Biol. 2016 May;94(5):447-57. doi: 10.1038/icb.2015.116.

2016

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

Crighton G, Wood E, Scarborough R, Ho PJ, Bowden D (2016).

Intern Med J 46(7):770-9.

May 2016

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Laubach J, Garderet L, Mahindra A, Gahrton G, Caers J, Sezer O, Voorhees P, Leleu X, Johnsen HE, Streetly M, Jurczyszyn A, Ludwig H, Mellqvist UH, Chng WJ, Pilarski L, Einsele H, Hou J, Turesson I, Zamagni E, Chim CS, Mazumder A, Westin J, Lu J, Reiman T, Kristinsson S, Joshua D, Roussel M, O’Gorman P, Terpos E, McCarthy P, Dimopoulos M, Moreau P, Orlowski RZ, Miguel JS, Anderson KC, Palumbo A, Kumar S, Rajkumar V, Durie B, Richardson PG.

Leukemia. 2016 May;30(5):1005-17. doi: 10.1038/leu.2015.356. Epub 2015 Dec 29. Review.

APRIL 2016

Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT).

Dyer G, Larsen SR, Gilroy N, Brice L, Greenwood M, Hertzberg M, Kabir M, Brown L, Hogg M, Huang G, Moore J, Gottlieb D, Kwan J, Tan J, Ward C, Kerridge I.

Cancer Med. 2016 Apr 25. doi: 10.1002/cam4.729. [Epub ahead of print]

2016

A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.

Dyer G, Gilroy N, Bradford J, Brice L, Kabir M, Greenwood M, Larsen SR, Moore J, Hertzberg M, Kwan J, Brown L, Hogg M, Huang G, Tan J, Ward C, Kerridge I.

Br J Haematol. 2016 Feb;172(4):592-601. doi: 10.1111/bjh.13872. Epub 2015 Dec 21.

2016

What They Want: Inclusion of Blood and Marrow Transplanation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia.

Dyer G, Gilroy N, Brown L, Hogg M, Brice L, Kabir M, Greenwood M, Larsen SR, Moore J, Hertzberg M, Kwan J, Huang G, Tan J, Ward C, Kerridge I.

Biol Blood Marrow Transplant. 2016 Apr;22(4):731-43. doi: 10.1016/j.bbmt.2015.12.019. Epub 2015 Dec 30.

2016

Recombinant to modified factor VIII and factor IX – chromogenic and one-stage assays issues.

Kitchen, S., Kershaw, G. and Tiefenbacher, S.

Haemophilia 2016; 22: 72–77. doi:10.1111/hae.13012.

2016

Design and development of the Australian and New Zealand Myeloma (ANZ) and Related Diseases Registry. 

Krystal Bergin; Elizabeth Moore; Zoe McQuilten; Erica Wood; Bradley Augustson; Hilary Blacklock; Joy Ho; Noemi Horvath; Tracy King; Neil McNeil; Peter Mollee; Hang Quach; Christopher Reid; Brian Rosengarten; Patricia Walker; Andrew Spencer. (2016).

BMC Medical Research Methodology. 2016. 16:151 DOI 10.1186/s12874-016-0250-z